| P2093 | author name string | Yasushi Saito | |
| | Nobuhiro Yamada | |
| | Tomoichiro Asano | |
| | Masanobu Kawakami | |
| | Fidarestat Clinical Pharmacology Study Group | |
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| | Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes | Q28257146 |
| | Effects of aldose reductase inhibitor (ONO-2235) on human erythrocyte sorbitol concentrations in 75 g oral glucose tolerance tests | Q28333388 |
| | The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients | Q28342183 |
| | Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects | Q28572164 |
| | Diabetic neuropathies: features and mechanisms. | Q33603470 |
| | Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus | Q38120921 |
| | Pharmacological properties of fidarestat, a potent aldose reductase inhibitor, clarified by using sorbitol in human and rat erythrocytes | Q43612929 |
| | Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study | Q43748985 |
| | Oxygen affinity of hemoglobin and peripheral nerve degeneration in experimental diabetes | Q70155946 |
| | Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats | Q71489787 |
| | Biochemical factors influencing erythrocyte deformability and capillary entrance phenomena | Q72029100 |
| | Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy | Q73049405 |
| | Inhibitory effects of fidarestat on aldose reductase and aldehyde reductase activity evaluated by a new method using HPLC with post-column spectrophotometric detection | Q73519819 |
| | Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats | Q74228997 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 133-138 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Diabetes and its Complications | Q15763696 |
| P1476 | title | Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients | |
| P478 | volume | 16 | |